In addition to the previously discussed molecules that have an established role in the development of prostate cancer and obesity, there are many molecules in the literature that may influence the pathogenesis of prostate cancer and obesity (e.g., visfatin, omentin, resistin, LCN2, FABP4, osteopontin, etc.)[151]. Here, ITLN1 is linked to obesity due to melanocortin 4 receptor deficiency.